XML 12 R39.htm IDEA: XBRL DOCUMENT v3.3.0.814
INTANGIBLE ASSETS (Details ) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2015
Dec. 31, 2014
Finite-Lived Intangible Assets    
Accumulated Amortization $ (135,936) $ (113,640)
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 1,460,220 1,342,228
Net Amount 1,324,284 1,228,588
Hormone therapy drug candidate patents - Pending [Member]    
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 585,241 675,982
Net Amount 585,241 675,982
Multiple trademarks for vitamins/supplements [Member]    
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 145,783 103,368
Net Amount 145,783 103,368
OPERA software patent [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 31,951 31,951
Accumulated Amortization (3,994) (2,496)
Net Amount $ 27,957 $ 29,455
Weighted Average Amortization Period 14 years 14 years 9 months
Development costs for corporate website [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount $ 91,743 $ 91,743
Accumulated Amortization $ (91,743) $ (91,743)
Net Amount
Approved Hormone Therapy Drug Candidate Patents [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount $ 605,502 $ 439,184
Accumulated Amortization (40,199) (19,401)
Net Amount $ 565,303 $ 419,783
Weighted Average Amortization Period   18 years
Non-Amortizing Intangible Assets [Member]    
Finite-Lived Intangible Assets    
Weighted Average Amortization Period 17 years 2 months 30 days